Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression.

Source:http://linkedlifedata.com/resource/pubmed/id/12496481

Download in:

View as

General Info

PMID
12496481